HOME >> BIOLOGY >> NEWS
M. D. Anderson team identifies new oncogene for brain cancer

HOUSTON -- An overexpressed gene found at the scene of a variety of tumors is implicated in the development of two types of malignant brain cancer in a paper by researchers at The University of Texas M. D. Anderson Cancer Center to be published in the Proceedings of the National Academy of Sciences. The paper will be posted online at the PNAS web site the week of July 2.

Just because a gene is associated with cancer doesnt mean that its actually causing cancer. In this paper we show for the first time that insulin-like growth factor binding protein 2 (IGFBP2) connects with two other proteins to fuel development and progression of brain tumors, says senior author Wei Zhang, Ph.D., professor in M. D. Andersons Department of Pathology.

Using a gene transfer delivery system in a mouse model, a team led by Zhang and Professor of Pathology Gregory Fuller, M.D., Ph.D., shows that IGFBP2 plays an active role in the tumorigenesis of astrocytoma and oligodendroglioma. Both cancers are forms of glioma, cancers that develop in the glial cells which normally support and nourish neurons -- that are highly resistant to treatment.

This makes IGFBP2 an important candidate for development of targeted therapy to treat gliomas, Zhang says. Gliomas kill about 13,000 people in the United States annually.

The possibilities are not limited to brain cancer, Fuller notes, because of the pervasive overexpression of IGFBP2 documented in other cancer types. The gene is expressed only at low levels in normal cells, which would potentially reduce side effects caused by a treatment that targeted the gene or its protein product.

Fuller and Zhang first associated overexpression of the gene with brain cancer in 1999. Other researchers have since found it to be overexpressed in prostate, ovarian, breast and colorectal cancers, some leukemias, and also in drug-resistant tumors.

Overabundance of IGFBP2 has since been shown to be a
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
2-Jul-2007


Page: 1 2 3

Related biology news :

1. New research identifies anti-viral protein that may predict who might be at risk to develop lupus
2. U-M team identifies gene that regulates blood-forming fetal stem cells
3. Study identifies new gene therapy tools for inherited blindness
4. Study identifies energy efficiency as reason for evolution of upright walking
5. Study identifies a common genetic risk factor for colorectal and prostate cancer
6. Weill Cornell team identifies potential new cancer drug target
7. Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
8. 454 sequencing identifies HIV drug resistance at early stage
9. Ultra deep sequencing identifies HIV drug resistance at early stage
10. Research team identifies new Alzheimers gene
11. A researcher identifies the parasites responsible for Chagas and Leishmaniasis epidemics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/11/2020)... , ... March 11, 2020 , ... ... telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces a ... 100,000 people in over 100 countries and has caused over 4,000 fatalities to ...
(Date:3/10/2020)... ... March 10, 2020 , ... Cytonus Therapeutics ... Dr. Narasimhan is Senior Vice President of Strategic Initiatives, Portfolio Innovation and Investor ... Directors of Cytonus, we are extremely pleased to welcome Manisha Narasimhan as an ...
(Date:3/5/2020)... ... March 05, 2020 , ... With numerous products in ... GmbH to accelerate Cytonus’ existing products and to expand the companies’ intellectual property ... a biotech company located in Austria. , Phoenestra has developed IP assets ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, ... to the strain level, recently unveiled a novel DNA isolation product. , Shoreline ... isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... process solutions for the life sciences industry, today announced the opening of a ... Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office ...
(Date:2/11/2020)... , ... February 11, 2020 ... ... is pleased to announce the successful results from a long-term follow-up clinical ... the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, the ...
(Date:2/10/2020)... (PRWEB) , ... February 10, 2020 , ... R3 Medical ... Course March 13-14th, 2020 in Las Vegas. The course is hands on involving ... , For the past few years, the Comprehensive Stem Cell Training Course has received ...
Breaking Biology Technology:
Cached News: